compounded semaglutide diarrhea Side Effects: What Patients Should Know in 2025 FDA alerts health care providers,

Description

27, 2025 (GLOBE NEWSWIRE) -- Intro As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded FDA-recognized access pathways, emerging treatment formats, and enhanced clinical support structures designed to optimize sustainable weight management outcomes

The Mounjaro SmPC warns that gastrointestinal side effects such as nausea, vomiting and diarrhoea can lead to dehydration and, in some cases, worsening kidney function

Sustainable outcomes will require comprehensive support systemsnot just prescriptions

One issue that I have come across is excessive pregnancy weight gain after stopping a weight loss medication for pregnancy, said Isaacs

Semaglutide has been used for weight loss in clinical trials for up to Ozempic and Rybelsus are intended for long-term use in managing type 2 diabetes